200 related articles for article (PubMed ID: 22031315)
1. p63 immunohistochemical staining is limited in soft tissue tumors.
Jo VY; Fletcher CD
Am J Clin Pathol; 2011 Nov; 136(5):762-6. PubMed ID: 22031315
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
Hornick JL; Fletcher CD
Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
[TBL] [Abstract][Full Text] [Related]
3. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
5. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
6. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
7. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
8. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
Bahrami A; Folpe AL
Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
[TBL] [Abstract][Full Text] [Related]
9. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
10. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Ahrens WA; Ridenour RV; Caron BL; Miller DV; Folpe AL
Hum Pathol; 2008 Oct; 39(10):1519-26. PubMed ID: 18620729
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation.
Dickson BC; Riddle ND; Brooks JS; Pasha TL; Zhang PJ
Hum Pathol; 2013 Jun; 44(6):1125-30. PubMed ID: 23332867
[TBL] [Abstract][Full Text] [Related]
12. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
13. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
[TBL] [Abstract][Full Text] [Related]
14. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
Min KW; Seo IS; Pitha J
Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
[TBL] [Abstract][Full Text] [Related]
15. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
16. Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part XII: appendix.
Bisceglia M; Spagnolo D; Galliani C; Fisher C; Suster S; Kazakov DV; Cooper K; Michal M
Pathologica; 2006 Aug; 98(4):239-98. PubMed ID: 17175794
[TBL] [Abstract][Full Text] [Related]
17. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity.
Murphy AJ; Bishop K; Pereira C; Chilton-MacNeill S; Ho M; Zielenska M; Thorner PS
Hum Pathol; 2008 Dec; 39(12):1763-70. PubMed ID: 18703217
[TBL] [Abstract][Full Text] [Related]
18. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.
Hornick JL; Bundock EA; Fletcher CD
Am J Surg Pathol; 2009 Oct; 33(10):1554-61. PubMed ID: 19623031
[TBL] [Abstract][Full Text] [Related]
19. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma.
Thway K; Fisher C; Debiec-Rychter M; Calonje E
Hum Pathol; 2009 Nov; 40(11):1586-90. PubMed ID: 19540561
[TBL] [Abstract][Full Text] [Related]
20. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
